Contrary to the "fetal origins" hypothesis and suggestions of a strong inverse relationship between birthweight and subsequent blood cholesterol levels, a recent study finds that 1-kg lower birthweight may be associated with at most about 2.0 mg/dL (0.05 mmol/L) higher total cholesterol later in life—an amount unlikely to have much impact on public health.
Contrary to the "fetal origins" hypothesis and suggestions of a strong inverse relationship between birthweight and subsequent blood cholesterol levels, a recent study finds that 1-kg lower birthweight may be associated with at most about 2.0 mg/dL (0.05 mmol/L) higher total cholesterol later in life-an amount unlikely to have much impact on public health.
Researchers who reviewed 79 studies involving more than 74,000 people found overwhelming heterogeneity in the results, leading them to conclude that previously reported associations between birthweight and later cholesterol levels probably reflect inappropriately placed emphasis on particular study results and inappropriate adjustment for current weight and other confounding factors.
Huxley R, Owen CG, Whincup PH, et al. Birth weight and subsequent cholesterol levels: exploration of the "fetal origins" hypothesis. JAMA. 2004;292:2755-2764.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More